Aspen Pharmacare Holdings Ltd (APNJ.J)

APNJ.J on Johannesburg Stock Exchange

27,800.00ZAc
17 Apr 2014
Price Change (% chg)

220.00c (+0.80%)
Prev Close
27,580.00c
Open
27,780.00c
Day's High
27,800.00c
Day's Low
27,504.00c
Volume
413,067
Avg. Vol
983,657
52-wk High
28,999.00c
52-wk Low
18,005.00c

APNJ.J

Chart for APNJ.J

About

Aspen Pharmacare Holdings Limited is a pharmaceutical company. The Company through its subsidiaries, is engaged in the manufacture, marketing and distribution of branded and generic pharmaceutical, as well as consumer, OTC and nutritional products in selected territories, operating primarily in the healthcare industry. The... (more)

Overall

Beta: 0.60
Market Cap (Mil.): R126,859.50
Shares Outstanding (Mil.): 456.33
Dividend: 157.00
Yield (%): 0.56

Financials

  APNJ.J Industry Sector
P/E (TTM): 33.65 32.99 33.14
EPS (TTM): 8.26 -- --
ROI: 8.41 19.69 18.95
ROE: 17.08 20.38 19.71
Search Stocks

BRIEF- Aspen Pharmacare sees H1 HEPS up 12 pct to 16 pct

JOHANNESBURG, Feb 21 - Aspen Pharmacare Holdings Ltd : * Says headline earnings per share for six months ended 31 December 13 expected

21 Feb 2014

BRIEF-Aspen acquires two GSK brands and a manufacturing site

JOHANNESBURG, Dec 31 - Aspen Pharmacare Holdings Ltd : * Says acquisition of the GSK's manufacturing business expected to complete during Q2 of 2014 * Material operations of GSK's Arixtra And Fraxiparine/Fraxodi brands to be transferred to co on 1 January 2014

31 Dec 2013

Some South African clinics running short of HIV/AIDS drugs: MSF

JOHANNESBURG - One in five South African clinics are running short of life-saving HIV/AIDS drugs, affecting nearly half a million people and undermining the success of the world's largest treatment program, medical charities said on Thursday.

28 Nov 2013

Some South African clinics running short of HIV/AIDS drugs - MSF

JOHANNESBURG, Nov 28 - One in five South African clinics are running short of life-saving HIV/AIDS drugs, affecting nearly half a million people and undermining the success of the world's largest treatment programme, medical charities said on Thursday.

28 Nov 2013

GlaxoSmithKline completes sale of Aspen shares, raising $694 million

LONDON - GlaxoSmithKline said on Wednesday it had completed the sale of 28.2 million shares in Aspen Pharmacare at 250 rand each, raising gross proceeds of 7.059 billion rand ($694 million).

20 Nov 2013

GlaxoSmithKline completes sale of Aspen shares, raising $694 mln

LONDON, Nov 20 - GlaxoSmithKline said on Wednesday it had completed the sale of 28.2 million shares in Aspen Pharmacare at 250 rand each, raising gross proceeds of 7.059 billion rand ($694 million).

20 Nov 2013

BRIEF-GlaxoSmithKline completes partial sale of Aspen Pharmacare Holdings

Nov 20 - GlaxoSmithKline Plc : * GSK completes partial sale of Aspen pharmacare holdings ltd shares * Raising gross proceeds of ZAR 7,059 million * Source text for Eikon: * For more news, please click here

20 Nov 2013

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: Wright Reports
$75.00
Provider: Directors Deals Ltd.
$12.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks